Literature DB >> 10849732

Natural substrates of dipeptidyl peptidase IV.

I De Meester1, C Durinx, G Bal, P Proost, S Struyf, F Goossens, K Augustyns, S Scharpé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10849732     DOI： 10.1007/0-306-46826-3_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  13 in total

1.  Membrane-associated dipeptidyl peptidase IV is involved in encystation-specific gene expression during Giardia differentiation.

Authors:  María C Touz; María J Nores; Ileana Slavin; Lucía Piacenza; Daniel Acosta; Carlos Carmona; Hugo D Luján
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

Review 2.  Incretin-based therapies in type 2 diabetes mellitus.

Authors:  Chee W Chia; Josephine M Egan
Journal:  J Clin Endocrinol Metab       Date:  2008-07-15       Impact factor: 5.958

3.  The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study.

Authors:  Adrian Vella; Gerlies Bock; Paula D Giesler; Duane B Burton; Denise B Serra; Monica Ligueros Saylan; Carolyn F Deacon; James E Foley; Robert A Rizza; Michael Camilleri
Journal:  Clin Endocrinol (Oxf)       Date:  2008-03-10       Impact factor: 3.478

4.  Modulation of Hematopoietic Chemokine Effects In Vitro and In Vivo by DPP-4/CD26.

Authors:  Hal E Broxmeyer; Maegan Capitano; Timothy B Campbell; Giao Hangoc; Scott Cooper
Journal:  Stem Cells Dev       Date:  2016-03-30       Impact factor: 3.272

Review 5.  New regulatory mechanisms for human extravillous trophoblast invasion.

Authors:  Hiroshi Fujiwara; Yukiyasu Sato; Yoshihiro Nishioka; Shinya Yoshioka; Kenzo Kosaka; Haruko Fujii; Keiji Tatsumi; Miho Egawa; Bin-Xiang Zeng; Kazumi Furukawa; Toshihiro Higuchi
Journal:  Reprod Med Biol       Date:  2005-07-28

6.  Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII.

Authors:  Barbara Leiting; KellyAnn D Pryor; Joseph K Wu; Frank Marsilio; Reshma A Patel; Charles S Craik; Jonathan A Ellman; Richard T Cummings; Nancy A Thornberry
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

7.  Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.

Authors:  Tatsuhito Himeno; Hideki Kamiya; Keiko Naruse; Norio Harada; Nobuaki Ozaki; Yusuke Seino; Taiga Shibata; Masaki Kondo; Jiro Kato; Tetsuji Okawa; Ayako Fukami; Yoji Hamada; Nobuya Inagaki; Yutaka Seino; Daniel J Drucker; Yutaka Oiso; Jiro Nakamura
Journal:  Diabetes       Date:  2011-08-01       Impact factor: 9.461

8.  Sensory and motor physiological functions are impaired in gastric inhibitory polypeptide receptor-deficient mice.

Authors:  Tetsuji Okawa; Hideki Kamiya; Tatsuhito Himeno; Yusuke Seino; Shin Tsunekawa; Yoshitaka Hayashi; Norio Harada; Yuichiro Yamada; Nobuya Inagaki; Yutaka Seino; Yutaka Oiso; Jiro Nakamura
Journal:  J Diabetes Investig       Date:  2013-10-16       Impact factor: 4.232

9.  Rapid and sensitive detection of early esophageal squamous cell carcinoma with fluorescence probe targeting dipeptidylpeptidase IV.

Authors:  Haruna Onoyama; Mako Kamiya; Yugo Kuriki; Toru Komatsu; Hiroyuki Abe; Yosuke Tsuji; Koichi Yagi; Yukinori Yamagata; Susumu Aikou; Masato Nishida; Kazuhiko Mori; Hiroharu Yamashita; Mitsuhiro Fujishiro; Sachiyo Nomura; Nobuyuki Shimizu; Masashi Fukayama; Kazuhiko Koike; Yasuteru Urano; Yasuyuki Seto
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

Review 10.  Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes.

Authors:  Bernd Richter; Elizabeth Bandeira-Echtler; Karla Bergerhoff; Christian Lerch
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.